Roche Partners With China's Hansoh in Deal That Could Top $15 Billion — Update
Roche Holding AG ADR RHHBY
News
Roche Partners With China's Hansoh in Deal That Could Top $15 Billion
Roche Gets FDA Approval for Enspryng to Treat Thyroid Eye Disease
AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro
Roche Licenses Obesity Therapy From China's Rona in Up to $1.2 Billion Deal
Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion
Roche Halts Development of Obesity Drug Candidate
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial — Update
European Pharma Leaders Push for National Reforms to Boost Investment
Roche's Susvimo Gets European Union Approval
Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
Roche, Simcere Pharma Strike Drug Licensing Deal
FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly
Hanmi Pharmaceutical Shares Jump After Signing $2.31 Billion Licensing Deal With Genentech
Roche's U.S. Subsidiary Genentech to Invest $750 Million in Manufacturing Expansion
'I didn't know what else to do': Patients take their health-insurance battles to Facebook and LinkedIn
Roche Launches Two Cyclospora Testing Options
Roche Backs Full-Year View as First-Half Sales Rise
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
United States